Category : Search result: paediatric medicine


Methylene Blue: The Dangerous Wellness Trend

Wellness influencers are drinking methylene blue dye despite serious health risks. Learn why this textile dye is causing concern among medical experts and poison centres.

UK Plan: Microchips to Replace Lab Rats in Testing

The UK government accelerates its plan to replace animal testing with advanced alternatives like 'organs-on-chips' and 3D bioprinting. Discover the timeline and the science behind this ethical shift.

PEMF Therapy Mats: Health Benefits Examined

Explore the science behind PEMF therapy mats. Experts weigh in on their potential for pain relief versus evidence-based treatments for chronic conditions in the UK.

Nurse on trial over fatal hospital monitoring error

A senior nurse faces gross negligence manslaughter charges after a seven-year-old boy died when she failed to reconnect his monitors at a private London hospital. The trial continues at Southwark Crown Court.

NHS faces generic-only drug future warns AstraZeneca

The CEO of pharmaceutical giant AstraZeneca warns that UK patients may be limited to generic medicines unless the NHS increases what it pays for innovative new treatments, raising concerns about healthcare quality and medical research funding.

Girl, 5, dies from leukaemia family knew nothing about

The heartbreaking story of five-year-old Lila Smith, whose leukaemia went undetected until it was too late, has prompted her family to launch a vital awareness campaign about childhood cancer symptoms.

Art as Medicine: How Culture Heals Body and Mind

Groundbreaking research reveals how museums, galleries and cultural experiences are being prescribed by doctors to treat everything from chronic pain to mental health conditions, transforming healthcare in Britain.

UK Pharma Crisis: Patients Face Treatment Delays

A critical pricing dispute between the UK government and pharmaceutical companies threatens patient access to vital medicines, with industry leaders warning of treatment delays and reduced NHS access to new drugs.

Page 1 of 1